<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR18">
 <label>18.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Robert</surname>
    <given-names>C</given-names>
   </name>
   <name>
    <surname>Long</surname>
    <given-names>GV</given-names>
   </name>
   <name>
    <surname>Schachter</surname>
    <given-names>J</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Long-term outcomes in patients (pts) with ipilimumab (ipi)-naive advanced melanoma in the phase 3 KEYNOTE-006 study who completed pembrolizumab (pembro) treatment</article-title>
  <source>J Clin Oncol</source>
  <year>2017</year>
  <volume>35</volume>
  <issue>15_suppl</issue>
  <fpage>9504</fpage>
  <pub-id pub-id-type="doi">10.1200/JCO.2017.35.15_suppl.9504</pub-id>
 </element-citation>
</ref>
